Glioblastoma, isocitric dehydrogenase (IDH)-wildtype

Clinical trials for Glioblastoma, isocitric dehydrogenase (IDH)-wildtype explained in plain language.

Never miss a new study

Get alerted when new Glioblastoma, isocitric dehydrogenase (IDH)-wildtype trials appear

Sign up with your email to follow new studies for Glioblastoma, isocitric dehydrogenase (IDH)-wildtype, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Sound waves open brain barrier to attack deadly tumor

Disease control Recruiting now

This trial tests a new approach for glioblastoma, an aggressive brain cancer. A device implanted in the skull uses ultrasound to temporarily open the blood-brain barrier, allowing immune-boosting drugs to reach the tumor. The study involves 25 adults who have completed radiation,…

Matched conditions: GLIOBLASTOMA, ISOCITRIC DEHYDROGENASE (IDH)-WILDTYPE

Phase 2 • Sponsor: Northwestern University • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC

Glioblastoma, isocitric dehydrogenase (IDH)-wildtype

Get alerted when new Glioblastoma, isocitric dehydrogenase (IDH)-wildtype trials appear

Sound waves open brain barrier to attack deadly tumor